NCT01425788View on ClinicalTrials.gov

Comparison of Different Up-dosing Schedules With Osiris Phleum Pratense

PHASE2CompletedINTERVENTIONAL
Enrollment

236

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

February 29, 2012

Conditions
Rhino-conjunctivitis
Interventions
BIOLOGICAL

Osiris Phleum pratense

BIOLOGICAL

Osiris Phleum pratense

BIOLOGICAL

Osiris Phleum pratense

Trial Locations (1)

90-153

Poradnia Alergologii i Chorob Pluc Uniwersyteckiego Szpitala Klinicznego Nr1 im. N. Barlickiego w Lodzi, Lodz

Sponsors
All Listed Sponsors
collaborator

Ergomed

INDUSTRY

collaborator

ACM Pivotal Global Central Laboratory

INDUSTRY

collaborator

Brecon Pharmaceuticals Ltd

UNKNOWN

lead

ALK-Abelló A/S

INDUSTRY